145 related articles for article (PubMed ID: 24532490)
1. Does dexamethasone induce more neuropsychological side effects than prednisone in pediatric acute lymphoblastic leukemia? A systematic review.
Warris LT; van den Heuvel-Eibrink MM; den Hoed MA; Aarsen FK; Pieters R; van den Akker EL
Pediatr Blood Cancer; 2014 Jul; 61(7):1313-8. PubMed ID: 24532490
[TBL] [Abstract][Full Text] [Related]
2. A comparison of neurocognitive functioning in children previously randomized to dexamethasone or prednisone in the treatment of childhood acute lymphoblastic leukemia.
Kadan-Lottick NS; Brouwers P; Breiger D; Kaleita T; Dziura J; Liu H; Chen L; Nicoletti M; Stork L; Bostrom B; Neglia JP
Blood; 2009 Aug; 114(9):1746-52. PubMed ID: 19546477
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychological outcomes of a randomized trial of prednisone versus dexamethasone in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute All Consortium Protocol 00-01.
Waber DP; McCabe M; Sebree M; Forbes PW; Adams H; Alyman C; Sands SA; Robaey P; Romero I; Routhier MÈ; Girard JM; Sallan SE; Silverman LB
Pediatr Blood Cancer; 2013 Nov; 60(11):1785-91. PubMed ID: 23832430
[TBL] [Abstract][Full Text] [Related]
4. Steroid withdrawal syndrome during steroid tapering in childhood acute lymphoblastic leukemia: a controlled study comparing prednisone versus dexamethasone in induction phase.
Saracco P; Bertorello N; Farinasso L; Einaudi S; Barisone E; Altare F; Corrias A; Pastore G
J Pediatr Hematol Oncol; 2005 Mar; 27(3):141-4. PubMed ID: 15750445
[TBL] [Abstract][Full Text] [Related]
5. Predicting the neurobehavioral side effects of dexamethasone in pediatric acute lymphoblastic leukemia.
Warris LT; van den Akker EL; Aarsen FK; Bierings MB; van den Bos C; Tissing WJ; Sassen SD; Veening MA; Zwaan CM; Pieters R; van den Heuvel-Eibrink MM
Psychoneuroendocrinology; 2016 Oct; 72():190-5. PubMed ID: 27448086
[TBL] [Abstract][Full Text] [Related]
6. HRQOL implications of treatment with dexamethasone for children with acute lymphoblastic leukemia (ALL).
Eiser C; Davies H; Jenney M; Stride C; Glaser A
Pediatr Blood Cancer; 2006 Jan; 46(1):35-9. PubMed ID: 15926164
[TBL] [Abstract][Full Text] [Related]
7. Concurrent treatment of steroid-related mood and psychotic symptoms with risperidone.
Ularntinon S; Tzuang D; Dahl G; Shaw RJ
Pediatrics; 2010 May; 125(5):e1241-5. PubMed ID: 20385646
[TBL] [Abstract][Full Text] [Related]
8. Bony morbidity in children treated for acute lymphoblastic leukemia.
Strauss AJ; Su JT; Dalton VM; Gelber RD; Sallan SE; Silverman LB
J Clin Oncol; 2001 Jun; 19(12):3066-72. PubMed ID: 11408503
[TBL] [Abstract][Full Text] [Related]
9. The impact of dexamethasone and prednisone on sleep in children with acute lymphoblastic leukemia.
Daniel LC; Li Y; Kloss JD; Reilly AF; Barakat LP
Support Care Cancer; 2016 Sep; 24(9):3897-906. PubMed ID: 27108263
[TBL] [Abstract][Full Text] [Related]
10. Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia.
Hurwitz CA; Silverman LB; Schorin MA; Clavell LA; Dalton VK; Glick KM; Gelber RD; Sallan SE
Cancer; 2000 Apr; 88(8):1964-9. PubMed ID: 10760775
[TBL] [Abstract][Full Text] [Related]
11. Hydrocortisone as an Intervention for Dexamethasone-Induced Adverse Effects in Pediatric Patients With Acute Lymphoblastic Leukemia: Results of a Double-Blind, Randomized Controlled Trial.
Warris LT; van den Heuvel-Eibrink MM; Aarsen FK; Pluijm SM; Bierings MB; van den Bos C; Zwaan CM; Thygesen HH; Tissing WJ; Veening MA; Pieters R; van den Akker EL
J Clin Oncol; 2016 Jul; 34(19):2287-93. PubMed ID: 27161966
[TBL] [Abstract][Full Text] [Related]
12. Steroid-induced alterations of behaviour during treatment for acute lymphoblastic leukaemia: a sibling's description.
Wei C
Arch Dis Child; 2011 Mar; 96(3):251. PubMed ID: 21252062
[No Abstract] [Full Text] [Related]
13. Results and conclusions of the European Intergroup EURO-LB02 trial in children and adolescents with lymphoblastic lymphoma.
Landmann E; Burkhardt B; Zimmermann M; Meyer U; Woessmann W; Klapper W; Wrobel G; Rosolen A; Pillon M; Escherich G; Attarbaschi A; Beishuizen A; Mellgren K; Wynn R; Ratei R; Plesa A; Schrappe M; Reiter A; Bergeron C; Patte C; Bertrand Y
Haematologica; 2017 Dec; 102(12):2086-2096. PubMed ID: 28983060
[TBL] [Abstract][Full Text] [Related]
14. The impact of maintenance therapy on sleep-wake rhythms and cancer-related fatigue in pediatric acute lymphoblastic leukemia.
Steur LMH; Kaspers GJL; van Someren EJW; van Eijkelenburg NKA; van der Sluis IM; Dors N; van den Bos C; Tissing WJE; Grootenhuis MA; van Litsenburg RRL
Support Care Cancer; 2020 Dec; 28(12):5983-5993. PubMed ID: 32285260
[TBL] [Abstract][Full Text] [Related]
15. Neurobehavioral side effects of corticosteroids during active treatment for acute lymphoblastic leukemia in children are age-dependent: report from Dana-Farber Cancer Institute ALL Consortium Protocol 00-01.
Mrakotsky CM; Silverman LB; Dahlberg SE; Alyman MC; Sands SA; Queally JT; Miller TP; Cranston A; Neuberg DS; Sallan SE; Waber DP
Pediatr Blood Cancer; 2011 Sep; 57(3):492-8. PubMed ID: 21560226
[TBL] [Abstract][Full Text] [Related]
16. Obesity after successful treatment of acute lymphoblastic leukemia in childhood.
Van Dongen-Melman JE; Hokken-Koelega AC; Hählen K; De Groot A; Tromp CG; Egeler RM
Pediatr Res; 1995 Jul; 38(1):86-90. PubMed ID: 7478803
[TBL] [Abstract][Full Text] [Related]
17. Development of acute lymphoblastic leukemia following hemophagocytic lymphohistiocytosis: is it secondary leukemia?
Suzuki T; Mugishima H; Yamada A; Nagata T; Shichino H; Chin M; Imashuku S; Harada K
Int J Hematol; 1999 Jul; 70(1):58-9. PubMed ID: 10446498
[No Abstract] [Full Text] [Related]
18. Body composition in long-term survivors of childhood acute lymphoblastic leukemia (ALL).
van der Sluis IM; van den Heuvel MM; de Muinck Keizer-Schrama SM
Med Pediatr Oncol; 2003 Jun; 40(6):407. PubMed ID: 12692817
[No Abstract] [Full Text] [Related]
19. Clinical impact of corticosteroid-induced adrenal suppression during treatment for acute lymphoblastic leukemia in children: a prospective observational study using the low-dose adrenocorticotropin test.
Rix M; Birkebaek NH; Rosthøj S; Clausen N
J Pediatr; 2005 Nov; 147(5):645-50. PubMed ID: 16291357
[TBL] [Abstract][Full Text] [Related]
20. Study protocol: DexaDays-2, hydrocortisone for treatment of dexamethasone-induced neurobehavioral side effects in pediatric leukemia patients: a double-blind placebo controlled randomized intervention study with cross-over design.
van Hulst AM; Verwaaijen EJ; Fiocco MF; Pluijm SMF; Grootenhuis MA; Pieters R; van den Akker ELT; van den Heuvel-Eibrink MM
BMC Pediatr; 2021 Sep; 21(1):427. PubMed ID: 34579671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
